Piper Jaffray Starts Pacira Pharmaceuticals (PCRX) at Overweight
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.00 -0.78%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray initiates coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with a Overweight. PT $14.
For more ratings news on Pacira Pharmaceuticals click here and for the rating history of Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $6.87 yesterday.
For more ratings news on Pacira Pharmaceuticals click here and for the rating history of Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $6.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
